The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison

被引：0
|
作者：
Theresa M. Ballard
Marie L. Woolley
Eric Prinssen
Jörg Huwyler
Richard Porter
Will Spooren
机构：
[1] F. Hoffmann-La Roche Ltd.,PRBD
[2] GlaxoSmithKline plc,N, Neuroscience Research
[3] F. Hoffmann-La Roche,Psychiatry CEDD
来源：
Psychopharmacology | 2005年 / 179卷
关键词：
MPEP; mGlu5 receptor antagonist; Anxiety; Cognition; Conflict task; Conditioned emotional response; Delayed match to position; Water maze; Rat;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：218 / 229
页数：11
相关论文
共 50 条
  • [31] The suppressive effect of metabotropic glutamate receptor 5 (mGlu5) inhibition on hepatocarcinogenesis
    Le Wu, Yong
    Wang, Nan Nan
    Gu, Li
    Yang, Hui Min
    Xia, Ning
    Zhang, Hong
    [J]. BIOCHIMIE, 2012, 94 (11) : 2366 - 2375
  • [32] Effects of MPEP, a selective metabotropic glutamate mGlu5 ligand, on sleep and wakefulness in the rat
    Cavas, Maria
    Scesa, Gianluigi
    Francisco Navarro, Jose
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 40 : 18 - 25
  • [33] Glutamate release inhibiting properties of the novel mGlu5 receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP):: complementary in vitro and in vivo evidence
    Thomas, LS
    Jane, DE
    Gasparini, F
    Croucher, MJ
    [J]. NEUROPHARMACOLOGY, 2001, 41 (04) : 523 - 527
  • [34] THE THERAPEUTIC POTENTIAL OF mGLU5 RECEPTOR ANTAGONISTS
    Spooren, W.
    [J]. BEHAVIOURAL PHARMACOLOGY, 2011, 22 : E11 - E11
  • [35] Effect of antagonism at metabotropic glutamate mGlu5 receptors by MPEP on oral ethanol self-administration in the mouse
    Marcon, C
    Andreoli, M
    Heidbreder, CA
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S23 - S23
  • [36] MPEP, an mGlu5 receptor allosteric modulator, reduces hepatic steatosis in obese high-fat-diet mice
    Di Pasqua, Laura Giuseppina
    Cagna, Marta
    Berardo, Clarissa
    Croce, Anna Cleta
    Nicoletti, Ferdinando
    Vairetti, Mariapia
    Ferrigno, Andrea
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 : S697 - S697
  • [37] mGlu5 receptor functional interactions and addiction
    Brown, Robyn M.
    Mustafa, Sanam
    Ayoub, Mohammed Akli
    Dodd, Peter R.
    Pfleger, Kevin D. G.
    Lawrence, Andrew J.
    [J]. FRONTIERS IN PHARMACOLOGY, 2012, 3
  • [38] mGlu5 receptor antagonists and their therapeutic potential
    Jaeschke, Georg
    Wettstein, Joseph G.
    Nordquist, Rebecca E.
    Spooren, Will
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2008, 18 (02) : 123 - 142
  • [39] The mGlu5 receptor antagonist MPEP activates specific stress-related brain regions and lacks neurotoxic effects of the NMDA receptor antagonist MK-801: Significance for the use as anxiolytic/antidepressant drug
    Inta, Dragos
    Filipovic, Dragana
    Lima-Ojeda, Juan M.
    Dormann, Christof
    Pfeiffer, Natascha
    Gasparini, Fabrizio
    Gass, Peter
    [J]. NEUROPHARMACOLOGY, 2012, 62 (5-6) : 2034 - 2039
  • [40] Description of a clinically validated Anxiolytic with mGlu5 antagonist properties
    Porter, R
    Jaeschke, G
    Spooren, W
    Ballard-Yardy, T
    Prinssen, E
    Muehlemann, A
    Wichmann, J
    Kolczewski, S
    Buettelmann, B
    Viera, E
    Mutel, V
    Malherbe, P
    [J]. NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S30 - S31
12345